combined commissioned drug therapies list · afamelanotide epp not commissioned not commissioned...

Key: Blue = NCB Yellow = Not commissioned

Combined Commissioned Drug Therapies List

Approved Name Brand IndicationResponsible

Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance

TAG classification or

Prescribing

Responsibility (if any)

Further information &

responsible commissioner

Abacavir HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Abacavir and

lamivudine

Kivexa HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Abatacept CCG NHSCB is paediatric use

Abatacept Orencia Paediatric indications National Specialist

Commissioning

Not for primary

care prescribing

E3b Paediatric

Medicine:

Rheumatology

Hospital only

prescribing (Red)

Transfer to adult care from

16 years- upper limit 19th

birthdayAbatacept Orencia Rheumatoid arthritis (after

failure of conventional

DMARD)

Under review Not for primary

care prescribing

TA280 Under review http://guidance.nice.org.uk/

TA280

Abatacept Orencia Rheumatoid arthritis (after

failure of DMARDs and anti-

TNF)

CCG Commissioned.

Non Tariff. Notification

Not for primary

care prescribing

TA195 Hospital only

prescribing (Red)

http://guidance.nice.org.uk/

TA195

Abciximab ReoPro Prevention MI during PCTA CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA47 & CG94 Hospital only

prescribing (Red)


TA47

http://www.nice.org.uk/guid

ance/CG94Abiraterone Zytiga Metastatic castration

resistant prostate cancer

National Specialist

Commissioning

Not for primary

care prescribing

TA259 Hospital only

prescribing (Red)

ACE inhibitors in

combination with

Angiotensin II

antagonists

All CCG Not

commissioned

Not commissioned NICE CG 127 Not recommended for

use (Double Red)

http://publications.nice.org.

uk/hypertension-cg127

Adalimumab Humira Ankylosing spondylitis CCG Commissioned.


Not for primary

care prescribing

TA143 Hospital only

prescribing (Red)


TA143

Adalimumab Humira Behçet’s syndrome National Specialist

Commissioning

Not for primary

care prescribing

A3c Rheumatology Hospital only

prescribing (Red)

Adalimumab Humira Crohns CCG Commissioned.


Not for primary

care prescribing

TA187 Hospital only

prescribing (Red)


TA187

Adalimumab Humira Juvenile idiopathic

rheumatoid arthritis

National Specialist

Commissioning

Not commissioned NICe not

recommended


TA/Wave17/7

1

Issued: April 2013

https://www.engage.commissioningboard.nhs.uk/consultation/ssc-area-e/supporting_documents/e3bservicespec.pdf



http://guidance.nice.org.uk/TA280




http://publications.nice.org.uk/hypertension-cg127

http://publications.nice.org.uk/hypertension-cg127

https://www.engage.commissioningboard.nhs.uk/consultation/ssc-area-a/supporting_documents/a3cservicespec.pdf

http://guidance.nice.org.uk/TA/Wave17/7

http://guidance.nice.org.uk/TA/Wave17/7




Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Adalimumab Humira Paediatric indications National Specialist

Commissioning

Not for primary

care prescribing

E3b Paediatric

Medicine:

Rheumatology

E3c Paediatric

Medicine:

Gastroenterology;

Hepatology;

Hospital only

prescribing (Red)



birthday

Adalimumab Humira Psoriasis CCG Commissioned.


Not for primary

care prescribing

TA146 Hospital only

prescribing (Red)


TA146

Adalimumab Humira Psoriatic arthritis CCG Commissioned.


Not for primary

care prescribing

TA199 Hospital only

prescribing (Red)


TA199

Adalimumab Humira Rheumatoid arthritis CCG Commissioned.


Not for primary

care prescribing

TA130 Hospital only

prescribing (Red)


TA130

Adalimumab Humira Rheumatoid arthritis (after

failure of anti-TNF)

CCG Commissioned.


Not for primary

care prescribing

TA195 Hospital only

prescribing (Red)


TA195

Adalimumab Humira Ulcerative colitis (moderate

to severe, second line)

CCG Not

commissioned

Not commissioned TA262 Not recommended for

use (Double Red)


TA262

Adefovir Hepsera Chronic Hepatitis B National Specialist

Commissioning

Not for primary

care prescribing

TA96 Hospital only

prescribing (Red)

Service stays with CCGs.

Drugs to NCB

Afamelanotide EPP Not commissioned Not commissioned Not recommended for

use (Double Red)

Aflibercept wet AMD Not commissioned Not commissioned NICE in

development

Not recommended for

use (Double Red)

Agalsidase alfa and

beta

Fabrazyme/

Replagal

Fabry's disease National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Agomelatine Valdoxan Major Depressive Episodes Not commissioned Not commissioned TA231 Hospital only

prescribing (Red)


TA231

Aldesleukin Proleukin Licensed indication National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Alemtuzumab Behçet’s syndrome National Specialist

Commissioning

Not for primary

care prescribing


prescribing (Red)

Alemtuzumab CLL National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Alendronic Acid Generic Primary prevention

osteoporotic fragility

fractures in postmenopausal

women

CCG Commissioned.

In tariff.

Commissioned TA160 Hospital & GP

Prescribing (Double

Green)


ance/TA160

2

Issued: April 2013













http://www.nice.org.uk/guidance/TA160





Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Alendronic Acid Generic Secondary prevention



women

CCG Commissioned.

In tariff.


Prescribing (Double

Green)


TA161

Alfacalcidol Generic Preparation for

hyperparathyroidectomy

CCG Commissioned.

In tariff.

Commissioned GP Prescribing at

request of Trust

Specialist (Green)

Alglucosidase alfa Myozyme Pompe Disease National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Aliskiren Rasilex Essential hypertension CCG Not

commissioned

Not commissioned Not recommended for

use (Double Red)

MHRA safety report

Alitretinoin Toctino Severe refractory chronic

hand eczema

CCG Commissioned.


Not for primary

care prescribing

TA177 Hospital only

prescribing (Red)


TA177

All chemotherapy for

cancer indicationsNHSE Other drugs included in 8.1 and 8.2 not listed above

Alteplase Actilyse Acute ischaemic stroke Commissioned. In tariff

top up - no extra drug

charge

Not for primary

care prescribing

TA264 & TA52 &

TA122

Hospital only

prescribing (Red)


TA264

Amantadine Prophylaxis of Influenza CCG Not

commissioned


use (Double Red)


ance/TA158

Amantadine Treatment of Influenza CCG Not

commissioned


use (Double Red)


ance/TA168

Ambrisentan Volibris Pulmonary Arterial

Hypertension

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Not in MPSS/national

policy

Amifampridine Firdapse Lambert Eaton Syndrome National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Amiodarone Generic Supraventricular &

ventricular arrhythmias

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

NICE CG under review.


CG/Wave0/638

Amphotericin B

(liposomal)

Ambisome

Abelcet

Systemic fungal infections

as per BNF advice where

non liposomal contra-

indicated. For chronic

pulmonary aspergillosis see

antifungals

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Amprenavir HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

3

Issued: April 2013












Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Anagrelide Xagrid Thrombocythaemia CCG Commissioned.

In tariff.

Commissioned Yes Shared care available

(Amber)

Subject to funding transfer

Anakinra Kineret Cryopyrin-associated

periodic syndrome

National Specialist

Commissioning

Not for primary

care prescribing

E6a Metabolic

Disorders: Adult

E6b Metabolic

Disorders:

Children E6c

Metabolic

Disorders:

Laboratory

Hospital only

prescribing (Red)

Anakinra Kineret Rheumatoid arthritis CCG Not

commissioned

Not commissioned NICE CG 79 Not recommended for

use (Double Red)


CG79

Anakinra Kineret Specialised rheumatology National Specialist

Commissioning

Not for primary

care prescribing

A3c

Rheumatology,

Hospital only

prescribing (Red)

Anastrazole Generic Early oestrogen-receptor-

positive breast cancer post-

menopause.

CCG Commissioned.

In tariff.

Commissioned TA112 GP Prescribing at

request of Trust

Specialist (Green)


TA112

Anidulafungin Ecalta Invasive candiasis National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Anti-D

immunoglobulin

Rh-ve pregnant women National Specialist

Commissioning

Not for primary

care prescribing

TA156 Hospital only

prescribing (Red)

Antibiotics (IV for

nebulisation)

Cystic Fibrosis National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Anticoagulant self

monitoring (test

strips)

Coaguchec

k

INR monitoring CCG Commissioned.

In tariff.

Commissioned Hospital & GP

Prescribing (Double

Green)

Antifungals for CPA Various Chronic Pulmonary

Aspergillosis

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Antihaemophilic

Factor/von

Willebrand Factor

Complex

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Antilymphocyte

globulin

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Antioxidant

Nutritional

Supplements

All indications CCG Not

commissioned


use (Double Red)

Antipsychotics

(excluding

Clozapine)

Schizophrenia CCG Commissioned.

In tariff.

Commissioned NICE CG 82 Shared care available

(Amber)


CG82

4

Issued: April 2013

http://guidance.nice.org.uk/CG79









Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Antithrombin III Licensed indications National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Antithymocyte

immunoglobulin

Thymoglobu

line

Steroid resistant allograft

rejection in renal transplants

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Apixaban Eliquis For prevention of VTE after

total hip or knee

replacement in adults

CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA245 Hospital only

prescribing (Red)


TA245

Apixaban Eliquis Prevention of stroke and

systemic embolism (non-

valvular atrial fibrillation)

Under review Under review TA275 Under review http://guidance.nice.org.uk/

TA275

Apomorphine Parkinson's Disease CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Local Homecare delivery

arrangement

Aripiprazole Abilify Schizophrenia CCG Commissioned.

In tariff.

Commissioned Yes NICE CG 82 Shared care available

(Amber)


CG82

Aripiprazole Abilify Schizophrenia 15 to 17 yrs CCG Commissioned.

In tariff.

Commissioned Yes TA213 Shared care available

(Amber)


TA213

Aromatase inhibitors Various Adjuvant hormonal

treatment of early oestrogen

receptor positive breast

cancer in post menopausal

women

CCG Commissioned.

In tariff.

Commissioned NICE CG 80 GP Prescribing at

request of Trust

Specialist (Green)


CG80

Atazanavir Reyataz HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Atomoxetine ADHD CCG Commissioned.

In tariff.


(Amber)


TA98

Autologous serum

eye drops

Dry eye Not commissioned Not commissioned Not recommended for

use (Double Red)

Axitinib Renal cell carcinoma National Specialist

Commissioning

Not for primary

care prescribing

NICE in progress

Azacitidine Vidaza Myelodysplasia, CML, AML National Specialist

Commissioning

Not for primary

care prescribing

TA218 Hospital only

prescribing (Red)

Azathioprine Generic UC/Crohns CCG Commissioned.

In tariff.


(Amber)

Aztreonam Cystic Fibrosis National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Aztreonam Lysine NHSE CCG if prescribed by GPs (when delivered via nebulisation/inhalation)

5

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Baclofen Intrathecal Pump National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Basiliximab Simulect Prophylaxis allograft

rejection renal transplant at

specialist centres

National Specialist

Commissioning

Not for primary

care prescribing

TA85 & TA99 Hospital only

prescribing (Red)

Becaplermin Regranex Diabetic ulcers CCG Commissioned.

In tariff.

Not commissioned Hospital only

prescribing (Red)

Belatacept Renal transplant National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Belimumab Benlysta Active SLE Not commissioned Not commissioned NICE in

development

Not yet considered Due Mar 2013

Belimumab Renal transplant National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Bendamustine CLL First line National Specialist

Commissioning

Not for primary

care prescribing

TA216 Hospital only

prescribing (Red)

Bendamustine Refractory low grade NHL National Specialist

Commissioning


use (Double Red)


TA206

Beractant Survanta Respiratory distress

syndrome neonates

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Betaine Cystadane Homocystinuria National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Bevacizumab Avastin Metastatic breast cancer

(first line)

Not commissioned Not commissioned TA147 Not recommended for

use (Double Red)


TA147


with capecitabine (first line)


use (Double Red)


TA263


with taxane (first line)


use (Double Red)


ance/TA214

Bevacizumab Avastin Metastatic colorectal cancer Not commissioned Not commissioned TA242 Not recommended for

use (Double Red)

Bevacizumab Avastin Metastatic colorectal cancer

2nd line


use (Double Red)


TA212

Bevacizumab Avastin Metastatic renal carcinoma Not commissioned Not commissioned TA178 Not recommended for

use (Double Red)


TA178

Bevacizumab Avastin NSCLC NCB Not

commissioned


use (Double Red)


TA148

Bevacizumab Avastin Renal cell carcinoma (first

line)


use (Double Red)

Bexarotene CTCL National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

6

Issued: April 2013


















Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Bilvarudin STEMI Treatment CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA230 Hospital only

prescribing (Red)


TA230

Boceprevir Victrelus Hepatitis C National Specialist

Commissioning

Not for primary

care prescribing

TA253 Hospital only

prescribing (Red)


Drugs to NCB

Bortezomib Velcade Multiple myeloma First Line National Specialist

Commissioning

Not for primary

care prescribing

TA228 Hospital only

prescribing (Red)

Bortezomib Velcade Relapsed multiple myeloma National Specialist

Commissioning

Not for primary

care prescribing

TA129 Hospital only

prescribing (Red)

Bosentan Tracleer Digital ulcers Not commissioned Not commissioned Not recommended for

use (Double Red)

Bosentan Tracleer Pulmonary Arterial

Hypertension

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Botulinum toxin A Achalasia and gastroparesis CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

Botulinum toxin A Blepharospasm CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

Botulinum toxin A Chronic anal fissure CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

Botulinum toxin A Chronic migraine CCG Commissioned in

line with NICE. Non

Tariff. Notification

Not for primary

care prescribing

TA260 Pathway to be

confirmed


TA260

Botulinum toxin A Focal spasticity CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

Botulinum toxin A Hemifacial spasm CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

Botulinum toxin A Neurogenic and non

neurogenic detrusor

overactivity in paediatric

patients who have not

responded to antimuscarinic

treatment

CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

Botulinum toxin A Oesophageal spasm and

nutcracker oesophagus

CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

7

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Botulinum toxin A Overactive bladder/detrusor

overactivity

CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

Botulinum toxin A Spasmodic torticollis CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

Botulinum toxin A Spasticity in neuromuscular

conditions

CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

Botulinum toxin B Spasmodic torticolis where

Botulinum A contra indicated

CCG Commissioned.


Not for primary

care prescribing

Local policy.

Notification

required

Hospital only

prescribing (Red)

Buprenorphine Transderma

l patches

Pain relief in patients with

renal impairment (CKD 4) at

risk opioid toxicity

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Buprenorphine Subutex Substance dependence CCG Commissioned.

In tariff.


(Amber)


TA114

Busulfan Generic Chemotherapy in line with

Network regimens

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

C1 Esterase inhibitor Berinert Allergic emergencies National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Cabazitaxel Jevtanat Second line hormone

refractory metastatic

prostate cancer

National Specialist

Commissioning

Not for primary

care prescribing

TA255 Hospital only

prescribing (Red)

Canakinumab Gout National Specialist

Commissioning

Not for primary

care prescribing

TA281 NICE not

recommended

(terminated appraisal)


TA281

Cancer treatments Anglia Cancer Network

Commissioned Therapies

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

http://www.angcn.nhs.uk/n

etwork-

groups/ccgs/chemotherapy

/documents.aspxCannabis (all forms

including Nabilone)

All indications CCG Not

commissioned


use (Double Red)

Cannabis spray Sativex Adjuvant moderate to severe

spasticity in MS

CCG Not

commissioned

Not commissioned NICE discontinued Not recommended for

use (Double Red)

Capecitabine Colon cancer National Specialist

Commissioning

Not for primary

care prescribing

TA100 Hospital only

prescribing (Red)

Capecitabine Colorectal cancer National Specialist

Commissioning

Not for primary

care prescribing

TA61 Hospital only

prescribing (Red)

8

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Capecitabine Gastric cancer (advanced) National Specialist

Commissioning

Not for primary

care prescribing

TA191 Hospital only

prescribing (Red)

Carglumic acid Carbaglu Hyperammonaemia National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Carmustine implant Newly diagnosed

glioblastoma multifomre


use (Double Red)

Carmustine implant Recurrent glioblastoma

multiforme


use (Double Red)


TA149

Cartinine Cartinor Primary & Secondary

Cartinine Deficiency

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Caspofungin Cancidas Systemic fungal infections.

For chronic pulmonary

aspergillosis see antifungals

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Ceftriaxone Cellulitis CCG Commissioned.

In tariff.


prescribing (Red)

Certolizumab Cimzia Rheumatoid arthritis CCG Commissioned.


Not for primary

care prescribing

TA186 Hospital only

prescribing (Red)


TA186

Certolizumab Cimzia Rheumatoid arthritis (after


CCG Commissioned.


Not for primary

care prescribing

TA195 Hospital only

prescribing (Red)


TA195

Certolizumab Pegol CCG NHSCB is paediatric use

Cetuximab Erbitux Colorectal cancer (first line) National Specialist

Commissioning

Not for primary

care prescribing

TA176 Hospital only

prescribing (Red)

Cetuximab Erbitux Head & Neck Cancer National Specialist

Commissioning

Not for primary

care prescribing

TA145 Hospital only

prescribing (Red)

Cetuximab Erbitux Head & Neck Cancer

(squamous cell)

NCB Not

commissioned


use (Double Red)


TA172

Cetuximab Erbitux Matestatic colorectal

(second line)

NCB Not

commissioned


use (Double Red)


TA242

Chlorambucil Generic Chemotherapy in line with

Network regimens

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Chlorpropamide T2DM Not commissioned Not commissioned Not recommended for

use (Double Red)

Ciclosporin Immunosuppression post

transplant

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Under review

Ciclosporin NHSE Post transplant only

Ciclosporin Generic Rheumatic & Dermatological

as per shared care

CCG Commissioned.

In tariff.


(Amber)

Needs review

9

Issued: April 2013










Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Cidofovir Vistide CMV National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Cilostazol Peripheral Arterial Disease Not commissioned Not commissioned TA223 Not recommended for

use (Double Red)


TA223

Cinacalcet Mimpara Refractory secondary

hyperparathyroidism ESRD

National Specialist

Commissioning

Not for primary

care prescribing

TA117 Hospital only

prescribing (Red)


TA117

Cinacalcet NHSE Renal dialysis only

Cinacalcet Mimpara Secondary

hyperparathyroidism &

parathyroid cancer

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Ciprofloxacin Generic Anthrax exposure CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Cladribine Chemotherapy National Specialist

Commissioning


use (Double Red)

Clopidogrel Generic ACS without NSTEMI CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Clopidogrel Generic Ischaemic stroke; in

peripheral arterial/

multivascular disease; or

after MI only if aspirin not

suitable

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Clopidogrel Generic Post elective PCI bare metal

stent

CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Clopidogrel Generic Prevention artherosclerotic

events

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Clopidogrel Generic Prophylaxis pre-elective PCI CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Clopidogrel Generic STEMI CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Clozapine Clozaril

Denzapine

Zaponex


In tariff.

Not for primary

care prescribing

NICE CG 82 Hospital only

prescribing (Red)


CG82

10

Issued: April 2013




Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Co-careldopa Duodopa Advanced Parkinson's

Disease

NCB Not

commissioned


use (Double Red)

Co-careldopa

internal tube

intestinal gel

CCG Only when used as intestinal gel with internal tube

Colesevelam Cholestagel Primary

hypercholesterolaemia

Not commissioned Not commissioned Not recommended for

use (Double Red)

Colistimethate

sodium


Commissioning

Not for primary

care prescribing

TA276 All new patients

hospital only. Existing

shared care to be

repatriated to hospital

in line with TAG


TA276

Colistimethate

sodium NHSE CCG if prescribed by GPs (when delivered via nebulisation/inhalation)

Collagenase Dupuytren's contracture Not commissioned Not commissioned Not recommended for

use (Double Red)

CCG

Combination drugs CCG Not

commissioned

Not for primary

care prescribing

Not recommended for

use (Double Red)

Under review

Conestat alfa Hereditary angiodema National Specialist

Commissioning


use (Double Red)

Corticosteroids

(Topical)

Atopic eczema CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Corticosteroids for

Adults (Inhaled)

Chronic asthma (adults) CCG Commissioned.

In tariff.


Prescribing (Double

Green)

NICE advises least costly

suitable product where

recommended. Where

combined with LABA, the

least costly product is

recommendedCorticosteroids for

Children (Inhaled)

Chronic asthma (children) CCG Commissioned.

In tariff.


Prescribing (Double

Green)

NICE advises least costly

suitable product where

recommended. Where

combined with LABA, the

least costly product is

recommendedCOX II Inhibitors Pain & inflammation in OA

or RA

CCG Commissioned.

In tariff.

Commissioned CG59 & CG79 Hospital & GP

Prescribing (Double

Green)

11

Issued: April 2013






Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Cyclophosphamide Generic Chemotherapy in line with

Network regimens

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Cytotoxic drugs Chemotherapy IV or

intrathecal

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Dabigatran Pradaxa Stroke & systemic embolism

prevention in non-valvular

AF

CCG Commissioned.

In tariff.

Commissioned Consult

CCG

Prescribing

Advisor re

Funding

TA249 Hospital & GP

Prescribing (Double

Green)


TA249

Dabigatran Pradaxa VTE prevention hip or knee

surgery

CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA157 Hospital only

prescribing (Red)


TA157

Daclizumab Immunosuppression post

renal transplant

National Specialist

Commissioning

Not for primary

care prescribing

Yes TA85 & TA99 Hospital only

prescribing (Red)

Darbepoetin Aranesp Anaemia associated with

renal failure in pre-dialysis

patients


use (Double Red)

Darbepoetin Aranesp Anaemia assocociated with

chronic renal failure in

dialysis patients

National Specialist

Commissioning

Not for primary

care prescribing


prescribing (Red)


ance/CG114

Darbepoetin Aranesp Cancer treatment induced

anaemia


use (Double Red)


TA142

Darbopoetin NHSE Renal dialysis only

Darunavir Prezista HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Dasatinib Sprycel CML (intolerant,resistant to

imatinib)

National Specialist

Commissioning


use (Double Red)


TA241

Decitabine Acute myeloid leukamia National Specialist

Commissioning

Not commissioned TA270 NICE not

recommended



TA270

Deferasirox Exjade Chronic iron overload

related to frequent blood

transfusions in patients with

thalassaemia major

National Specialist

Commissioning

Not for primary

care prescribing

Under

review

All new patients


shared care to be


in line with TAG

Shared care for review

Deferiprone Ferriprox Chronic iron overload

related to frequent blood

transfusions

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

12

Issued: April 2013



http://www.nice.org.uk/guidance/CG114







Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Defibrotide National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Denosumab Prolia Bone loss non-metastatic

prostate cancer


use (Double Red)


TA194

Denosumab Prolia Bone mets from solid

tumours

CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA265 Hospital only

prescribing (Red)


TA265

Denosumab Prolia Primary prevention fractures

postmenopausal women

CCG Commissioned.

In tariff.


(Amber)


TA204

Desferrioxamine Anaemia related to chronic

iron overload

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Dexamethasone Ozurdex Macular oedema (retinal

vein occlusion)

CCG Commissioned.


Not for primary

care prescribing

TA229 Hospital only

prescribing (Red)


TA229

Dexamfetamine ADHD CCG Commissioned.

In tariff.


(Amber)


TA98

Dexrazoxane National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Diaminopyridine Treatment of mysathenias National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Dibotermin alfa Incalcitrant non-union long

bones

CCG Commissioned.


Not for primary

care prescribing

Hospital only

prescribing (Red)

http://www.eoescg.nhs.uk/

Libraries/Policies_Docs/Bo

ne_Morphogenic_Protein_

Policy_Feb_2010.sflb.ashx

Didanosine Videx HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Dimethyl fumarate MS Relapsing Remitting National Specialist

Commissioning

Not for primary

care prescribing

NICE in progress

Dipyridamole MR After an ischaemic stroke if

aspirin and clopidogrel

unsuitable; or after a TIA if

aspirin unsuitable

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Dipyridamole MR

with aspirin

After a TIA; or after an

ischaemic stroke only if

clopidogrel unsuitable

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Docetaxel Generic Advanced breast cancer National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Docetaxel Early node positive breast

cancer

National Specialist

Commissioning

Not for primary

care prescribing

TA109 Hospital only

prescribing (Red)

13

Issued: April 2013






Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Docetaxel Generic In place of paclitaxel causing

peripheral neuropathy in

patients with ovarian cancer

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Docetaxel Generic NSCLC National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Docetaxel Generic Prostate cancer National Specialist

Commissioning

Not for primary

care prescribing

TA101 Hospital only

prescribing (Red)

Donepezil Generic Alzheimer's disease (mild to

moderate)

CCG Commissioned.

In tariff.


(Amber)


TA217

Dornase alfa Pulmozyme Cystic fibrosis National Specialist

Commissioning

Not for primary

care prescribing

Yes All new patients


shared care to be


in line with TAG

guidance

Bronchiecstasis in tariff.

TAG needs review

Doxorubicin

(liposomal)

Ovarian cancer (advanced) National Specialist

Commissioning

Not for primary

care prescribing

TA91 Hospital only

prescribing (Red)

Doxycycline Generic Anthrax exposure CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Dried Prothrombin Licensed indications National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Dronedarone Multaq AF non permanent CCG Commissioned.

In tariff.


(Amber)


TA197

Duloxetine Yentreve Moderate to severe stress

urinary incontinence

CCG Commissioned.

In tariff.


(Amber)

Ecallantide Allergic emergencies National Specialist

Commissioning

Not commissioned TBC

Eculizumab Soliris Paroxysmal nocturnal

haemoglobinuria

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Efalex Unlicensed Dyslexia Not commissioned Not commissioned Not recommended for

use (Double Red)

Efavirenz Sustiva HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Eflornithine Vaniqua Hirsuitism. In line with TAG

guidance

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

14

Issued: April 2013






Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Eltrombopag Revolade Chronic immune or

idiopathic thrombocytopenic

purpura


use (Double Red)


TA205

Emtricitabine Emtriva HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Emtricitabine and

tenofovir

Truvada HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Enfurvirtide Fuzeon HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Entecavir Baraclude Chronic Hepatitis B National Specialist

Commissioning

Not for primary

care prescribing

TA153 Hospital only

prescribing (Red)


Drugs to NCB

Enteral Nutrition Various PEG & NG feeding CCG Commissioned.

In tariff.


Prescribing (Double

Green)


CG32

Eplerenone Second line therapy for

heart failure patients

intolerant to spironolactone

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Epoetin Generic Anaemia associated with

chronic renal failure in

dialysis patients

National Specialist

Commissioning

Not for primary

care prescribing


prescribing (Red)


ance/CG114

Epoetin Generic Anaemia associated with

renal failure in pre-dialysis

patients


use (Double Red)

Epoetin NHSE Renal dialysis only

Epoetin alfa or beta Generic Cancer treatment induced

anaemia


use (Double Red)


TA142

Epoprostenol Flolan Adult Respiratory Distress

Syndrome

National Specialist

Commissioning


use (Double Red)

Epoprostenol Flolan Pulmonary Arterial

Hypertension

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Epoprostenol Flolan Renal dialysis when use of

heparin carries a high risk of

causing or exacerbating

bleeding or when heparin is

otherwise contraindicated

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

15

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Epotermin alfa Osigraft Long bone union CCG Commissioned.


Not for primary

care prescribing

Hospital only

prescribing (Red)

http://www.eoescg.nhs.uk/

Libraries/Policies_Docs/Bo

ne_Morphogenic_Protein_

Policy_Feb_2010.sflb.ashx

Eptifibatide Integralin Prevention MI unstable

angina

CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA47 Hospital only

prescribing (Red)


TA47

Eribulin Havalen Locally advanced metastatic

breast cancer

Not commissioned Not commissioned TA250 NICE not

recommended


TA250

Erlotinib Tarceva Locally advanced or

metastatic EGFR-TK

mutation positive NSCLC

First line

National Specialist

Commissioning

Not for primary

care prescribing

TA258 Hospital only

prescribing (Red)

Erlotinib Tarceva Monotherapy maintenance

NSCLC

National Specialist

Commissioning


recommended


TA227

Erlotinib Tarceva NSCLC Second line National Specialist

Commissioning

Not for primary

care prescribing

TA162 Hospital only

prescribing (Red)

Escitalopram Cipralex Anxiety disorders Not commissioned Not commissioned Not recommended for

use (Double Red)

Estramustine Chemotherapy in line with

Network regimens

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Etanercept Enbrel Ankylosing spondylitis CCG Commissioned.


Not for primary

care prescribing

TA143 hospital only

prescribing (Red)


TA143

Etanercept Enbrel Behcet's National Specialist

Commissioning

Not for primary

care prescribing


prescribing (Red)

Etanercept Enbrel Idiopathic juvenile

rheumatoid arthritis. Any

other paediatric indications

National Specialist

Commissioning

Not for primary

care prescribing

E3b Paediatric

Medicine:

Rheumatology

Hospital only

prescribing (Red)



birthday


TA35

Etanercept CCG NHSCB is paediatric use

Etanercept Enbrel Psoriasis CCG Commissioned.


Not for primary

care prescribing

TA103 Hospital only

prescribing (Red)


TA103

Etanercept Enbrel Psoriatic arthritis CCG Commissioned.


Not for primary

care prescribing

TA199 Hospital only

prescribing (Red)


TA199

Etanercept Enbrel Rheumatoid arthritis CCG Commissioned.


Not for primary

care prescribing

TA130 Hospital only

prescribing (Red)


TA130

16

Issued: April 2013












Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Etanercept Enbrel Rheumatoid arthritis (after


CCG Commissioned.


Not for primary

care prescribing

TA195 Hospital only

prescribing (Red)


TA195

Etidronate Didronel

PMO

Primary prevention



women

CCG Commissioned.

In tariff.


Prescribing (Double

Green)


ance/TA160

Etidronate Didronel

PMO

Secondary prevention



women

CCG Commissioned.

In tariff.


Prescribing (Double

Green)


TA161

Etonogestrel/Ethinyl

oestradiol

Nuvaring Medium acting reversible

contraception where oral

and transdermal options are

unsuitable

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Etonorgestrel/Ethinyl

oestradiol

NuvaRing Contraception CCG Commissioned.

In tariff.

Commissioned Consultant initiates

script for continuation

by GP (Green)

Etoposide Chemotherapy in line with

Network regimens

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Etravirine Intelence HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Everolimus Advanced RCC second line National Specialist

Commissioning


recommended


TA219

Exemestane Adjuvant treatment of

oestrogen-receptor-positive

early breast cancer

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)


CG80

Exemestane Early oestrogen-receptor-


menopause.

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)


TA112

Exenatide Byetta Co-use with insulin under

specified local criteria

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Local policy

Exenatide Byetta Type II diabetes CCG Commissioned.

In tariff.


(Amber)


CG66

Exenatide prolonged

release

Byetta LAR Type II diabetes CCG Commissioned.

In tariff.


(Amber)


TA248

17

Issued: April 2013
















Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Ezetimibe Heterozygous-familial and

non-familial

hypercholesterolaemia with

a statin or as monotherapy if

a statin unsuitable.

CCG Commissioned.

In tariff.


Prescribing (Double

Green)


TA132

Ezetimibe (and

combination

products)

Adjunct in lowering LDL

levels in patients with type 2

diabetes to below 3mmol/l


use (Double Red)

Ezetimibe (and

combination

products)

Adjunct to dietary measures

in homozygous familial

hypercholesterolaemia and

sitosterolaemia

CCG Commissioned.

In tariff.

Commissioned TAG Nov 2004 Hospital & GP

Prescribing (Double

Green)

Factor VII VIII/VwF

VwF IX VIIa VIII

FEIBA XIII XI FFP

Fibrinogen Topical

Thrombin Platelets

Octaplase

Licensed indications National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Fampridine Multiple Sclerosis National Specialist

Commissioning

Not commissioned NICE scoping

Febuxostat Adenuric Hyperuricaemia intolerant to

allopurinol

CCG Commissioned.

In tariff.


Prescribing (Double

Green)


TA164/Guidance/pdf/Engli

sh

Fentanyl Abstral 3rd line option breakthrough

cancer pain

CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Fentanyl Instanyl

Effentora

Actiq

Breakthrough pain in cancer Not commissioned Not commissioned Not recommended for

use (Double Red)

Fibrin sealants

CCG Commissioned.

Non Tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

FibrinogenNational Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Fibroblast growth

factor 1 gene

therapy

NHSECCG is used for non cancer

use

Fibroblast growth

factor 1 gene

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

18

Issued: April 2013






Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Filgrastim Neutropenia National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Filibuvir Hepatitis C National Specialist

Commissioning

Not for primary

care prescribing

Addenbrookes &

NNUH Specialist

prescribing only in

line with EoE policy &

proformaFingolimod Gilenia MS primary progressive National Specialist

Commissioning

Not commissioned NICE in development

Fingolimod Gilenia MS relapsing remitting National Specialist

Commissioning

Not for primary

care prescribing

TA254 Hospital only

prescribing (Red)

Fish Oils ADHD Not commissioned Not commissioned Not recommended for

use (Double Red)

Fish Oils (Omega 3) Familial

Hypercholesterolaemia

Not commissioned Not commissioned NICE CG 71 Not recommended for

use (Double Red)


CG71

Fludarabine CLL First line Monotherapy Not commissioned Not commissioned TA119 Not recommended for

use (Double Red)


TA119

Fludarabine CLL Second line National Specialist

Commissioning

Not for primary

care prescribing

TA29 Hospital only

prescribing (Red)

Fluocinolone DMO Not commissioned Not commissioned TA271 Not recommended for

use (Double Red)


TA271

Fluocinolone

acetonideCCG only when used as an intravitreal implant

Fomepizole Poisoning Commissioned in line

with National Poisons

Centre Guidance

Not for primary

care prescribing

Poisons Centre

Prescribing Only

Fondaparinux Arixtra Prophylaxis VTE in

orthopaedic surgery


use (Double Red)

Fondaparinux Arixtra Unstable angina/MI CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Fosamprenavir Telzir HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Foscarnet Foscavir CMV National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Fosphenytoin Status epilepticus Not commissioned Not commissioned Not recommended for

use (Double Red)

Fresh frozen plasma Licensed indications National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

19

Issued: April 2013










Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Fulvestrant Locally advanced or

metastatic breast cancer


use (Double Red)


TA239

Fumaric acid ester Fumaderm Psoriasis CCG Commissioned.

In tariff.


prescribing (Red)

Gabapentin Generic Neuropathic Pain CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Galantamine Reminyl Alzheimer's disease (mild to

moderate)

CCG Commissioned.

In tariff.


(Amber)


TA217

Galsufase Naglazyme Mucopolysaccharidosis National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Gamolenic Acid All Not commissioned Not commissioned Not recommended for

use (Double Red)

Ganciclovir CMV National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Gefitinib NSCLC 1st line National Specialist

Commissioning

Not for primary

care prescribing

TA192 Hospital only

prescribing (Red)

Gefitinib NSCLC 2nd line National Specialist

Commissioning


recommended


TA175

Gemcitabine Generic Breast cancer National Specialist

Commissioning

Not for primary

care prescribing

TA116 Hospital only

prescribing (Red)

Gemcitabine Generic NSCLC National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Gemcitabine Generic Pancreatic cancer National Specialist

Commissioning

Not for primary

care prescribing

TA25 Hospital only

prescribing (Red)

Glatiramer Copaxone MS National Specialist

Commissioning

Not for primary

care prescribing

TA32 Funded DH risk

sharing scheme

Hospital Only

Glibenclamide T2DM Not commissioned Not commissioned Not recommended for

use (Double Red)

Glucosamine All indications Not commissioned Not commissioned Not recommended for

use (Double Red)

Gluten free cakes,

biscuits & pizza

bases

Various Gluten sensitive

enteropathies


use (Double Red)

Local policy

Glycoprotein IIb &

IIIa

ACS CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA47 Hospital only

prescribing (Red)

20

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Glycopyrronium Hyperhidrosis CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Under review

Golimumab Simponi Ankylosing spondylitis CCG Commissioned.


Not for primary

care prescribing

TA233 Hospital only

prescribing (Red)


TA233

Golimumab CCG NHSCB is paediatric use

Golimumab Simponi Psoriatic arthritis CCG Commissioned.


Not for primary

care prescribing

TA220 Hospital only

prescribing (Red)


TA220

Golimumab Simponi RA methotrexate naïve Not commissioned Not commissioned TA224 Not recommended for

use (Double Red)


TA224

Golimumab Simponi Rheumatoid arthritis CCG Commissioned.


Not for primary

care prescribing

TA225 Hospital only

prescribing (Red)


TA225

Goserelin Zoladex Endometriosis, pre-

operative management

uterine fibroids

CCG Commissioned.

In tariff.


(Amber)

Goserelin Zoladex Prostate cancer CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Grass Pollen Extract Grasax Seasonal grass pollen

allergy


use (Double Red)

Heparin (LMW) Various Ante-natal VTE prevention CCG Not

commissioned

Not for primary

care prescribing

Not recommended for

use (Double Red)

Needs review

Heparin (LMW) Various DVT Out of Hours CCG Commissioned.

In tariff.


(Amber)

Heparin (LMW) Various DVT prevention during

flights


use (Double Red)

Heparin (LMW) Various Unstable angina/MI CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Heparin (LMW) Various Where warfarin contra-

indicated

CCG Commissioned.

In tariff.


(Amber)

Heparin

(unfractionated)

Various SC use in pregnancy CCG Commissioned.

In tariff.

Under review Under review Needs review

HIV/AIDs

Treatments

Various HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Homeopathic

preparations

Various All indications Not commissioned Not commissioned Not recommended for

use (Double Red)

HRT implants Various HRT CCG Commissioned.

In tariff.


Prescribing (Double

Green)

21

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Human Arginate All treatment of acute

porphyria outside of the

Highly Specialist Severe

Acute Porphyria Centres

(regardless of whether

advice is given by the

Specialist Centre or haem

arginate prescribed by the

Specialist Centre.All

treatment of acute porphyria

CCG Commissioned.


Not for primary

care prescribing

Hospital only

prescribing (Red)

Human Arginate Normosang Severe acute porphyria National Specialist

Commissioning

Not for primary

care prescribing

E6a Metabolic

Disorders: Adult

E6b Metabolic

Disorders:

Children E6c

Metabolic

Disorders:

Laboratory

Hospital only

prescribing (Red)

Hyal G-F 20 Synvisc Osteoarthritis Not commissioned Not commissioned Not recommended for

use (Double Red)

Hyaluronate Hyalgan Osteoarthritis Not commissioned Not commissioned Not recommended for

use (Double Red)

Hydroxycarbamide Hydrea CML/Myeloproliferative

disorders

National Specialist

Commissioning

Not for primary

care prescribing

Under

review

All new patients


shared care to be


in line with TAG

guidance


Hydroxycarbamide Hydrea Sickle Cell disease National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Fund holder to be

confirmed

Hydroxycarbamide Siklos Sickle Cell disease National Specialist

Commissioning


use (Double Red)

Fund holder to be

confirmed

Ibandronate Bondronat Reduction of bone damage

in bone mets in breast

cancer

CCG Commissioned.

In tariff.

Commissioned Yes Under review

Ibandronic acid Bonviva Osteoporosis treatment post

menopausal

CCG Commissioned.

In tariff.


prescribing (Red)

Icatibant Firazyr Allergic emergencies National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Within NCB specific

criteria

22

Issued: April 2013

https://www.engage.commissioningboard.nhs.uk/consultation/ssc-area-e/supporting_documents/e6aservicespec.pdf











Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Idarubicin Chemotherapy in line with

Network regimens

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Idursulfase Elaprase Mucopolysaccharidosis National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Iloprost Ventavis Pulmonary Arterial

Hypertension

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Imatinib Glivec Adjuvant treatment of

gastrointestinal stromal

tumours (GIST) after surgery

National Specialist

Commissioning


recommended


TA196

Imatinib Glivec CML National Specialist

Commissioning

Not for primary

care prescribing

TA251 Hospital only

prescribing (Red)

Imatinib Glivec CML 600mg & 800mg dose National Specialist

Commissioning


recommended


TA241

Imatinib Glivec Kit-positive unresectable

and /or metastatic GIST

National Specialist

Commissioning

Not for primary

care prescribing

TA86 Hospital only

prescribing (Red)

Imatinib Glivec Kit-positive unresectable

and /or metastatic GIST

600mg to 800mg daily

National Specialist

Commissioning

Not commissioned TA86 and TA209 NICE not

recommended


ance/TA209

Imiglucerase Cerezyme National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Immunoglobulin Various DH agreed indications only National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

http://www.ivig.nhs.uk/docu

ments/dh_129666.pdf

Indacaterol Onbreze COPD CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Indinavir Crixivan HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Infertility treatment Various Sub fertility National Specialist

Commissioning

Not for primary

care prescribing

NICE in progress Hospital only

prescribing (Red)

Fund holder to be

confirmed

Infliximab Remicade Ankylosing spondylitis Not commissioned Not commissioned TA143 Not recommended for

use (Double Red)


TA143

Infliximab Remicade Behcet's National Specialist

Commissioning

Not for primary

care prescribing


prescribing (Red)

Infliximab Remicade Crohns CCG Commissioned.


Not for primary

care prescribing

TA187 Hospital only

prescribing (Red)


TA187

Infliximab CCG NHSCB is paediatric use

23

Issued: April 2013





Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Infliximab Remicade Paediatric indications National Specialist

Commissioning

Not for primary

care prescribing

E3b Paediatric

Medicine:

Rheumatology

E3c Paediatric

Medicine:

Gastroenterology;

Hepatology;

Nutrition

Hospital only

prescribing (Red)



birthday

Infliximab Remicade Psoriasis (adults) CCG Commissioned.


Not for primary

care prescribing

TA134 Hospital only

prescribing (Red)


TA134

Infliximab Remicade Psoriatic arthritis CCG Commissioned.


Not for primary

care prescribing

TA199 Hospital only

prescribing (Red)


TA199

Infliximab Remicade Rheumatoid arthritis CCG Commissioned.


Not for primary

care prescribing

TA130 Hospital only

prescribing (Red)


TA130

Infliximab Remicade Rheumatoid arthritis (after


CCG Commissioned.


Not for primary

care prescribing

TA195 Hospital only

prescribing (Red)


TA195

Infliximab Remicade Sarcoidosis National Specialist

Commissioning

Not for primary

care prescribing

A3d4 Respiratory:

Interstitial Lung

Disease

Hospital only

prescribing (Red)

Infliximab Remicade Specialised renal services

for children & young people

National Specialist

Commissioning

Not for primary

care prescribing

E3a Paediatric

Medicine: Renal

Hospital only

prescribing (Red)

Infliximab Remicade Ulcerative colitis (acute

exacerbation)

CCG Commissioned.


Not for primary

care prescribing

TA163 Hospital only

prescribing (Red)


TA163

Infliximab Remicade Ulcerative colitis sub acute

manifestations


use (Double Red)


TA140

Influenza

(Intradermal)

Intanza Influenza prophylaxis Not commissioned Not commissioned Not recommended for

use (Double Red)

Inhaled

corticosteroids

Various Children with wheeze and a

cold


use (Double Red)

Inhaler devices Childhood asthma CCG Commissioned.

In tariff.

Commissioned TA38 & TA10 Hospital & GP

Prescribing (Double

Green)

Inositol nicotinate Hexopal Peripheral Arterial Disease Not commissioned Not commissioned TA225 Not recommended for

use (Double Red)


TA225

Insulin Diabetes CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

24

Issued: April 2013









https://www.engage.commissioningboard.nhs.uk/consultation/ssc-area-a/supporting_documents/a3d4servicespec.pdf








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Insulin Detemir Diabetes in adults (licensed)

& children (not licensed <18

yrs)

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Insulin Glargine Diabetes CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)


TA53

Insulin Glulisine Diabetes CCG Commissioned.

In tariff.

Commissioned NICE CG87 GP Prescribing at

request of Trust

Specialist (Green)


CG87

Insulin Pumps As agreed

in regional

framework

Type 1 Diabetes - children National Specialist

Commissioning

Not for primary

care prescribing

TA151 Hospital only

prescribing (Red)


TA151

Insulin Pumps As agreed

in regional

framework

Type 1 Diabetes Adults CCG Commissioned

according to regional

framework. Notification

Not for primary

care prescribing

TA151 Hospital only

prescribing (Red)


TA151

Interferon alfa Adjunct to surgery in

malignant melanoma

National Specialist

Commissioning


use (Double Red)

Interferon alfa Chronic myelogenous

leukaemia

National Specialist

Commissioning

Not for primary

care prescribing

Yes Hospital only

prescribing (Red)

Interferon alfa 2a or

2b

Chronic Hepatitis B National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)


Drugs to NCB

Interferon beta 1a &

1b

Avonex

Rebif

Betaferon

MS National Specialist

Commissioning

Not for primary

care prescribing

TA32 Funded DH risk

sharing scheme

Hospital Only

Intrauterine

progesterone only

system

Contraception, primary

menorrhagia

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Intravenous nutrition

(HPN)

Various Intestinal failure CCG Commissioned.


Not for primary

care prescribing

Hospital only

prescribing (Red)

Ipilimumab Melanoma National Specialist

Commissioning

Not for primary

care prescribing

TA268 Hospital only

prescribing (Red)


TA268

Irinotecan Colorectal cancer 2nd line National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Iron sorbitol Iron deficiency anaemia CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Isotretinoin Roaccutane Acne CCG Commissioned.

In tariff.


prescribing (Red)

25

Issued: April 2013




Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Ivabradine Chronic heart failure CCG Commissioned.

In tariff.

Commissioned TA267 Under review http://guidance.nice.org.uk/

TA267

Ivabradine Chronic stable angina when

betablockers are contra-

indicated or not tolerated

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Ivacaftor Cystic fibrosis National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

In line with NCB policy –

for all patients aged 6

years and over with cystic

fibrosis and the G551D

gene mutationLacosamide Adjunctive treatment

epilepsy

CCG Commissioned.

In tariff.


(Amber)

Lacosamide Vimpat Epilepsy CCG Commissioned.

In tariff.


(Amber)

Lamivudine Zeffix Chronic Hepatitis B National Specialist

Commissioning

Not for primary

care prescribing

TA96 Hospital only

prescribing (Red)


Drugs to NCB

Lamivudine Epivir HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Lamivudine and

zidovudine

Combivir HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Lamotrigine Generic Bipolar CCG Commissioned.

In tariff.


(Amber)

Lanreotide Acromegaly CCG Commissioned.


Under review Hospital only

prescribing (Red)

Needs review

Lanreotide Carcinoid & other endocrine

tumours

National Specialist

Commissioning

Not for primary

care prescribing

Yes Hospital only

prescribing (Red)

Lanreotide NHSE CCG is used for non cancer use

Lanthanum Hyperphosphataemia in end

stage renal failure

National Specialist

Commissioning


Prescribing (Red)

Needs review

Lanthanum NHSE Renal dialysis only

Lapatinib All indications National Specialist

Commissioning

Not commissioned NICE not

recommended

Laronidase Aldurazyme Mucopolysaccharidosis National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Leflunomide Arava Psoriatic and rheumatoid

arthritis

CCG Commissioned.

In tariff.


(Amber)

26

Issued: April 2013




Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Lenalidomide Multiple myeloma third line National Specialist

Commissioning

Not for primary

care prescribing

TA171 Hospital only

prescribing (Red)

Lenograstim Granocyte Neutropenia National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Letrozole Generic Early oestrogen-receptor-


menopause.

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)


TA112

Leuprorelin Prostap All other licensed indications CCG Commissioned.

In tariff.


(Amber)

Shared care via Hospital

letter

Leuprorelin Prostap Endometriosis, pre-


uterine fibroids

CCG Commissioned.

In tariff.


(Amber)

Levocartinine 1 and 2 secondary

carnitine deficiency

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Levonorgestrel

1500mcg

Post coital emergency

contraception

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Lidocaine patches Versatis Pain Not commissioned Not commissioned Not recommended for

use (Double Red)

Linezolid Zyvox Pneumonia, complex soft

tissue infections

CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Liraglutide Bydureon All other indications and

1.8mg strength


use (Double Red)

Liraglutide 1.2mg Bydureon T2DM CCG Commissioned.

In tariff.


(Amber)


TA203

Lithium Priadel

Camcolit

Liskonum

Bipolar CCG Commissioned.

In tariff.


(Amber)

TDM database registration

Lomustine Anglia Cancer Network


National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Lopinavir with

Ritonavir

HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Macitentan Pulmonary Arterial

Hypertension

National Specialist

Commissioning


use (Double Red)

Not on NCB draft list or

included in MPSS/national

policy, launch expected Q3

2013

Mannitol NHSE CCG if prescribed by GPs (when delivered via nebulisation/inhalation)

Mannitol Bronchitol CF secretion clearance National Specialist

Commissioning

Not for primary

care prescribing

TA266 Hospital only

prescribing (Red)

27

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Maraviroc HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Mecasermin Increlex Growth Failure in children National Specialist

Commissioning


prescribing (Red)

Melatonin All other indications CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Melatonin 2mg MR

Tablets

Circadin Short term treatment primary

insomnia in adults >55 years


use (Double Red)

Melatonin 2mg MR

Tablets

Circadin Sleep disorders in children

with ADHD

CCG Commissioned.

In tariff.


(Amber)

Meloxicam Generic OA Short term CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Melphalan Generic Anglia Cancer Network


National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Memantine Ebixa Alzheimer's disease CCG Commissioned.

In tariff.


(Amber)


TA217

Mercaptamine Cystagon Nephropathic cystinosis National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Mercaptopurine Chemotherapy National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Mercaptopurine Generic Steroid sparing UC/Crohns CCG Commissioned.

In tariff.


(Amber)

Methadone Generic Substance dependence CCG Commissioned.

In tariff.


(Amber)


TA114

Methotrexate Chemotherapy National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Methotrexate (oral &

SC)

Psoriasis, IBD, RA CCG Commissioned.

In tariff.


(Amber)


CG79

Methylnaltrexone Opioid induced bowel

dysfunction in palliative care

Not commissioned Not commissioned TA277 NICE not

recommended


TA277

Methylphenidate ADHD Children &

Adolescents

CCG Commissioned.

In tariff.


(Amber)


TA98

Micafungin Mycamine Systemic fungal infections National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Mifamurtide Osteosarcoma National Specialist

Commissioning

Not for primary

care prescribing

TA235 Hospital only

prescribing (Red)

28

Issued: April 2013






Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Miglustat Gauchers National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Miraviroc Celsentri HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Mitotane Adrenocortical carcinoma National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Modafinil Provigil All other indications Not commissioned Not commissioned Not recommended for

use (Double Red)

Modafinil Provigil Narcolepsy CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Montelukast Singulair Adults Step 3 or4 BTS/SIGN

Asthma guidance

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Montelukast Singulair Prophylaxis asthma in

children

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Motavizumab Chronic Hepatitis B National Specialist

Commissioning


use (Double Red)

Motavizumab Synagis Prevention LRTI due to RSV

infants

National Specialist

Commissioning

Not for primary

care prescribing

JCVI policy (Green

Book)

Hospital only

prescribing (Red)

Moxifloxacin Avelox Resistant cases TB in

patients exempt from

charges

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Needs review as TB

should be hospital only

Moxifloxacin Avelox Respiratory infection CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Mycophenolate Generic All other licensed indications CCG Not

commissioned

Not for primary

care prescribing

Not recommended for

use (Double Red)

No Shared Care for other

uses yet submitted to TAG

Mycophenolate Generic Dermatology Not commissioned Not commissioned Not recommended for

use (Double Red)

Mycophenolate Generic Immunosuppression post

renal transplant

National Specialist

Commissioning

Not for primary

care prescribing

Under

review

TA85 & TA99 All new patients


shared care to be


in line with TAG

guidance


Mycophenolate

mofetilNHSE Post transplant only

29

Issued: April 2013




Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Mycophenolate

motefil

Immunosuppression post

renal transplant


use (Double Red)

Mycophenolic acid NHSE Post transplant only

N-acetylcysteine Fluimicil

(unlicensed

in UK)

Idiopathic pulmonary fibrosis Not commissioned Not commissioned NICE CG 101 Not recommended for

use (Double Red)


CG101

Nabilone Pain & spasticity in MS Not commissioned Not commissioned Not recommended for

use (Double Red)

Naftidrofuryl Peripheral Arterial Disease CCG Commissioned.

In tariff.


Prescribing (Double

Green)


TA223

Naltrexone Alcohol use disorder -

maintenance of abstinence

CCG Commissioned.

In tariff.


(Amber)

Naltrexone Unlicensed Low dose (unlicensed) Not commissioned Not commissioned Not recommended for

use (Double Red)

Naltrexone Opiate dependence CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA115 Hospital only

prescribing (Red)


TA115

Natalizumab Tysabri Multiple Sclerosis National Specialist

Commissioning

Not for primary

care prescribing

TA127 Hospital only

prescribing (Red)

Nelfinavir Viracept HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Nevirapine Viramune HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Nicotine

replacement therapy

Various Smoking cessation CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Nilotinib CML (intolerant,resistant to

imatinib)

National Specialist

Commissioning

Not for primary

care prescribing

TA251 Hospital only

prescribing (Red)

Nitisinone Orfadin Tyrosinaemia Type I National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Nitric Oxide Neonatal use Not in MPSS/national

policy

Not for primary

care prescribing

Hospital only

prescribing (Red)

Fund holder to be

confirmed

Nutritional

Supplements as

listed in TAG

Various In line with NICE CG 32 CCG Commissioned.

In tariff.


(Amber)

http://publications.nice.org.

uk/nutrition-support-in-

adults-cg32

Ocriplasmin CCG Vitreomacular traction

National Specialist

Commissioning

Not for primary

care prescribing

NICE in progress

30

Issued: April 2013




Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Octreotide Acromegaly CCG Commissioned.



prescribing (Red)

Needs review

Octreotide Carcinoid & other

neuroendocrine tumours

National Specialist

Commissioning

Not for primary

care prescribing

Yes Hospital only

prescribing (Red)

Octreotide NHSE CCG is used for non cancer use

Octreotide Reducing vomiting in bowel

obstruction

National Specialist

Commissioning

Not for primary

care prescribing

Yes Hospital only

prescribing (Red)

Octreotide LA Use in a rare cancer National Specialist

Commissioning

Not for primary

care prescribing

Yes Hospital only

prescribing (Red)

Ofatumumab CLL refractory to fludarabine

& alemtuzumab


use (Double Red)


TA202

Olanzapine Generic Bipolar CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Olanzapine Generic Schizophrenia CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Omalizumab Xolair Severe persistent allergic

asthma in children aged 6

and over and adults

National Specialist

Commissioning

Not for primary

care prescribing

TA278 Hospital only

prescribing (Red)


TA278

Ondansetron & other

5HT3 antagonists

Nausea & vomiting CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Orlistat Generic Obesity CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Oseltamavir Treatment & prophylaxis

influenza in at risk groups

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Oxaliplatin Colon cancer National Specialist

Commissioning

Not for primary

care prescribing

TA100 Hospital only

prescribing (Red)

Oxcarbazepine Epilepsy CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Oxycodone &

Naloxone

Targinact Pain relief Not commissioned Not commissioned Not recommended for

use (Double Red)

Oxygen therapy Indications specified in

regional contract

Regional contract only Regional contract

only

Regional contract

only

31

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Paclitaxel Early node-positive breast

cancer.


use (Double Red)

Paclitaxel Lymph node positive breast

cancer


use (Double Red)

Paclitaxel Metastatic breast cancer

monotherapy

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Paclitaxel NSCLC National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Paclitaxel Ovarian cancer (advanced) National Specialist

Commissioning

Not for primary

care prescribing

TA91 Hospital only

prescribing (Red)

Palivizumab Synagis Prevention LRTI due to RSV

infants

National Specialist

Commissioning

Not for primary

care prescribing

JCVI policy (Green

Book)

Hospital only

prescribing (Red)

Panitumumab Metastatic colorectal cancer National Specialist

Commissioning


recommended

Panitumumab Metastatic colorectal cancer

2nd line

National Specialist

Commissioning


recommended


TA240

Parathyroid

Hormone

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Parenteral Nutrition NHSE

after 14 days or when the

patient is receiving

parenteral nutrition prior to

Pasireotide NHSE Chemotherapy

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Pazopanib Advanced RCC 1st line National Specialist

Commissioning

Not for primary

care prescribing

TA215 Hospital only

prescribing (Red)

Pegaptanib Macugen wet AMD Not commissioned Not commissioned TA155 Not recommended for

use (Double Red)


TA155

Pegfilgrastim Neutropenia National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Peginterferon alfa In combination with ribavirin

for Hep C

National Specialist

Commissioning

Not for primary

care prescribing

TA200 Hospital only

prescribing (Red)


Drugs to NCB

Peginterferon alfa Mild chronic Hepatitis C with

ribavirin

National Specialist

Commissioning

Not for primary

care prescribing

TA106 Hospital only

prescribing (Red)


Drugs to NCB

Peginterferon alfa 2a Chronic Hepatitis B National Specialist

Commissioning

Not for primary

care prescribing

TA96 Hospital only

prescribing (Red)


Drugs to NCB

Pegloticase Gout National Specialist

Commissioning

Not for primary

care prescribing

NICE in

development

Hospital only

prescribing (Red)

32

Issued: April 2013






Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Pegvisomant Somavert Acromegaly NCB Not

commissioned


use (Double Red)

Pemetrexed Malignant pleural

mesothelioma

National Specialist

Commissioning

Not for primary

care prescribing

TA135 Hospital only

prescribing (Red)

Pemetrexed NSCLC 1st line National Specialist

Commissioning

Not for primary

care prescribing

TA181 Hospital only

prescribing (Red)

Pemetrexed NSCLC after prior

chemotherapy

National Specialist

Commissioning


recommended


ance/TA124

Pemetrexed NSCLC maintenance National Specialist

Commissioning

Not for primary

care prescribing

TA190 Hospital only

prescribing (Red)

Pentoxyfylline Peripheral Arterial Disease Not commissioned Not commissioned TA224 NICE not

recommended


TA224

Pharmalgen Venom anaphylaxis CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA246 Hospital only

prescribing (Red)


TA246

Pimecrolimus Second line atopic eczema

where serious risk ADR from

topical steroid

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Pioglitazone T2DM CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Pirfenidone Esbriet Idiopathic pulmonary fibrosis National Specialist

Commissioning

Not for primary

care prescribing

TA282 Hospital only

prescribing (Red)


TA282

Plerixafor Mozobil Stem cell mobilsation National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Poractant alfa Curosurf Respiratory distress

syndrome neonates

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Posaconazole Noxafil Systemic fungal infections.



National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Pramipexole

immediate release

Generic Parkinsons CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Pramipexole

prolonged Release

Parkinson's Disease Not commissioned Not commissioned Not recommended for

use (Double Red)

Prasugrel ACS CCG Commissioned.

In tariff.

Commissioned Yes TA182 Consultant initiates

script for continuation

by GP (Green)


TA182

33

Issued: April 2013












Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Prasugrel Targeted use in diabetics

with ACS in combination

with aspirin


use (Double Red)

Pregabalin GAD CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Pregabalin Neuropathic pain CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Follow local treatment

pathway

Procarbazine All indications National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Progest cream All indications Not commissioned Not commissioned Not recommended for

use (Double Red)

Protein C

concentrate

Licensed indications National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Prothrombin

Complex

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Proton Pump

Inhibitors

Generic Dyspepsia CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Prucalopride Resolor Chronic constipation in

women

CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA211 Hospital only

prescribing (Red)


TA211

Quetiapine Generic Generalised anxiety disorder Not commissioned Not commissioned NICE suspended Not recommended for

use (Double Red)

Quetiapine Seroquel Schizophrenia CCG Commissioned.

In tariff.

Commissioned Yes NICE CG 82 GP Prescribing at

request of Trust

Specialist (Green)


CG82

Quetiapine Seroquel Severe depression with

bipolar - Tx and prevention


use (Double Red)

Policy in development

Ralitrexed Colorectal cancer Not commissioned Not commissioned Not recommended for

use (Double Red)

Raloxifene Evista Primary prevention



women


use (Double Red)


ance/TA160

Raloxifene Evista Secondary prevention



women

CCG Commissioned.

In tariff.


Prescribing (Double

Green)


TA161

34

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Raltegravir Isentress HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Ranibizumab Lucentis DMO Under review Under review TA237 Under review http://guidance.nice.org.uk/

TA237

Ranibizumab Lucentis RVO Not commissioned Not commissioned NICE in

development

Not recommended for

use (Double Red)

Ranibizumab Lucentis wet AMD CCG Commissioned.


Not for primary

care prescribing

TA155 Hospital only

prescribing (Red)


TA155

Ranolazine Adjunctive use in stable

angina

CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Rasagiline Parkinson's Disease CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Rasburicase Fasturtec Prophylaxis and treatment

hyperuricaemia with initial

chemotherapy

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Retigabine Epilepsy CCG Commissioned.

In tariff.


(Amber)


TA232

Ribavirin Chronic Hepatitis C in

combination with

Peginterferon

National Specialist

Commissioning

Not for primary

care prescribing

TA200 Hospital only

prescribing (Red)


Drugs to NCB

Ribavirin Mild chronic Hepatitis C with

Peginterferon

National Specialist

Commissioning

Not for primary

care prescribing

TA106 Hospital only

prescribing (Red)


Drugs to NCB

Rifamixin Secondary hepatic

encephalopathy

CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Riluzole ALS form of Motor Neurone

Disease

National Specialist

Commissioning

Under review TA20 Under review Needs review

Riociguat Pulmonary Arterial

Hypertension

NCB Not

commissioned


use (Double Red)

Not on draft NCB list or

included in MPSS/national

policy– expected launch

2014 Risedronate Generic Primary prevention



women

CCG Commissioned.

In tariff.


Prescribing (Double

Green)


ance/TA160

35

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Risedronate Generic Secondary prevention



women

CCG Commissioned.

In tariff.


Prescribing (Double

Green)


TA161

Risperidone Generic ADHD CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Risperidone Generic Schizophrenia CCG Commissioned.

In tariff.


(Amber)


CG82

Risperidone depot Risperdal

Consta


In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Ritonavir HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Rituximab Mabthera ABO-incompatible kidney

transplant

NCB Not

commissioned


use (Double Red)

Rituximab Mabthera ANCA vasculitis National Specialist

Commissioning

Not for primary

care prescribing

A3c1a Clinical

commissioning

policy Rituximab

and ANCA

Vasculitis

Hospital only

prescribing (Red)

Primary treatment failure or

if intolerant or contra-

indicated to

cyclophosphamide

Rituximab Mabthera CLL First line National Specialist

Commissioning

Not for primary

care prescribing

TA174 Hospital only

prescribing (Red)

Rituximab Mabthera Connective Tissue Disease National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Rituximab Mabthera Connective Tissue Disease

Interstitial lung disease

NCB Not

commissioned

Not commissioned A3d4 Respiratory:

Interstitial Lung

Disease

Not recommended for

use (Double Red)

Rituximab NHSE For cancer, renal, lung disease

Rituximab CCG For rheumatoid conditions - NHSCB if paediatrric use

Rituximab Mabthera Haemophilia National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Rituximab Mabthera Neuromyelitis optica National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Rituximab Mabthera NHL National Specialist

Commissioning

Not for primary

care prescribing

TA65 Hospital only

prescribing (Red)

Rituximab Mabthera Relapsed or refractory CLL National Specialist

Commissioning

Not for primary

care prescribing

TA193 Hospital only

prescribing (Red)

36

Issued: April 2013



https://www.engage.commissioningboard.nhs.uk/consultation/ssc-area-a/supporting_documents/a3c1apolicy.pdf











Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Rituximab Mabthera Relapsed or refractory Stage

III-IV FL

National Specialist

Commissioning

Not for primary

care prescribing

TA137 Hospital only

prescribing (Red)

Rituximab Mabthera Rheumatoid arthritis (after

failure DMARDs and anti-

TNF)

CCG Commissioned in

line with NICE & local

policy. Non Tariff.

Notification

Not for primary

care prescribing

TA195 Hospital only

prescribing (Red)


TA195

Rituximab Mabthera Severe refractory vasculitis NCB Not

commissioned


use (Double Red)

NCB commissions

treatment of severe

vasculitis – Rituximab is

not listed but MPSS states

that the NCB will decide on

which treatments should

be commissioned for the

indication

Rituximab Mabthera Severe SLE NCB Not

commissioned

Not commissioned A3c1b Clinical

commissioning

policy Rituximab

and Systemic

Lupus

erythematosus

Not recommended for

use (Double Red)

Rituximab Mabthera Specialist renal services for

children & young people

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Rituximab Mabthera Splenic NHL National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Rituximab Mabthera Stage III-IV FL (First line &

maintenance)

National Specialist

Commissioning

Not for primary

care prescribing

TA226 & 243 Hospital only

prescribing (Red)

Rivaroxaban Xerelto ACS Not commissioned Not commissioned NICE in

development

Not recommended for

use (Double Red)

Rivaroxaban Xerelto Prevention of stroke and

systemic embolism (non-

valvular atrial fibrillation)

CCG Commissioned.

In tariff.


CCG

Prescribing

Advisor re

Funding

TA256 Hospital & GP

Prescribing (Double

Green)


TA256

Rivaroxaban Xerelto Pulmonary Embolism -

Treatment

Not commissioned Not commissioned NICE in

development

Not recommended for

use (Double Red)

37

Issued: April 2013



https://www.engage.commissioningboard.nhs.uk/consultation/ssc-area-a/supporting_documents/a3c1bstatement.pdf











Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Rivaroxaban Xarelto Stroke prevention in AF CCG Commissioned.

In tariff.


CCG

Prescribing

Advisor re

Funding

TA256 Prescribing according

to local guidance


TA256

Rivaroxaban Xerelto VTE prophylaxis Not commissioned Not commissioned NICE suspended Not recommended for

use (Double Red)

Rivaroxaban Xerelto VTE prophylaxis hip or knee

surgery

CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA170 Hospital only

prescribing (Red)


TA170

Rivaroxaban Xerelto VTE treatment and long

term secondary prevention

CCG Commissioned.

In tariff.


CCG

Prescribing

Advisor re

Funding

TA261 Under review http://guidance.nice.org.uk/

TA261

Rivastigmine Exelon Alzheimer's disease CCG Commissioned in

line with NICE. Non



(Amber)


TA217

Roflumilast Daxas COPD (unless part of

agreed trial)


use (Double Red)


TA244

Romiplostim Nplate Chronic immune or

idiopathic thrombocytopenic

purpura

CCG Commissioned.


Not for primary

care prescribing

TA221 Hospital only

prescribing (Red)


TA221

Ropinirole Generic Parkinson's Disease CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Rotigotine Parkinson's Disease CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Ruxolitinib Myelofibrosis

National Specialist

Commissioning

Not for primary

care prescribing

NICE in progress

Salmeterol/Fluticaso

ne inhaler

Asthma prophylaxis CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Salmeterol/Fluticaso

ne inhaler

COPD CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Sapropterin Kuvan Phenylketouria National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

38

Issued: April 2013




Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Saquinavir HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Second line

DMARDs

RA CCG Commissioned.

In tariff.


(Amber)

Sevelamer Hyperphosphataemia National Specialist

Commissioning


Prescribing (Red)

Needs review

Sevelamer NHSE Renal dialysis only

Sildenafil Erectile dysfunction CCG Commissioned.

In tariff.


Prescribing (Double

Green)

http://www.dh.gov.uk/prod_

consum_dh/groups/dh_digi

talassets/@dh/@en/docum

ents/digitalasset/dh_40120

86.pdf

Sildenafil NHSE only when used for Pulmanory Arterial Hypertension

Sildenafil Pulmonary Arterial

Hypertension

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Silicone sheet

dressing

Scarring Not commissioned Not commissioned Not recommended for

use (Double Red)

Sirolimus Rapamune Immunosuppression post

renal transplant

National Specialist

Commissioning

Not for primary

care prescribing

Under

review



shared care to be


in line with TAG

guidance


Sirolimus NHSE Post transplant only

Sitagliptin T2DM CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Sodium Chloride

(Hypertonic)


Commissioning

Not for primary

care prescribing

Under

review

All new patients


shared care to be


in line with TAG

guidance


Sodium Clodronate Bone pain (mets) Fund holder TBC Under review Shared care needs review

39

Issued: April 2013




Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Sodium Oxybate Xyrem Cataplexy in adult patients

with narcolepsy

Under review Under review Under review Papworth sleep centre -

first three months supply

free from manufacturer.

High abuse potentialSodium

Phenylbutyrate

Ammonaps Urea cycle disorder National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Solifenacin Urge incontinence CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Somatropin Various Adult growth hormone

deficiency

CCG Commissioned.


Not for primary

care prescribing

TA64 Hospital only

prescribing (Red)


TA64

Somatropin Various Growth disturbance in

children small for gestational

age

CCG Commissioned.


Not for primary

care prescribing

TA188 Hospital only

prescribing (Red)


TA188

Somatropin Various Growth Failure in children CCG Commissioned.


Not for primary

care prescribing

TA188 Hospital only

prescribing (Red)


TA188

Sorafenib All indications National Specialist

Commissioning

Not commissioned TA189 & TA178 NICE not

recommended


TA189

SSRI

antidepressants

Generic Depression in children CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Statins Generic CVD & T2DM CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Stavudine Zerit HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Streptokinase MI- thrombolysis CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA94 Hospital only

prescribing (Red)

Strontium Protelos Primary prevention



women

CCG Commissioned.

In tariff.


Prescribing (Double

Green)


ance/TA160

Strontium Protelos Secondary prevention



women

CCG Commissioned.

In tariff.


Prescribing (Double

Green)


TA161

Sunitinib GIST National Specialist

Commissioning

Not for primary

care prescribing

TA179 Hospital only

prescribing (Red)

40

Issued: April 2013










Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Sunitinib RCC Second line National Specialist

Commissioning


recommended

Sunitinib Renal cell carcinoma (first

line)

National Specialist

Commissioning

Not for primary

care prescribing

TA169 Hospital only

prescribing (Red)

Tacrolimus Prograf

Advagraf

Immunosuppression post

renal transplant

National Specialist

Commissioning

Not for primary

care prescribing

Under

review



shared care to be


in line with TAG

guidance


Tacrolimus NHSE Post transplant only

Tacrolimus ointment Second line moderate to

severe atopic eczema

CCG Commissioned.

In tariff.


(Amber)

Tadalafil BPH Not commissioned Not commissioned TA273 Not recommended for

use (Double Red)


TA273

Tadalafil NHSE only when used for Pulmanory Arterial Hypertension

Tadalafil Pulmonary Arterial

Hypertension

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Tafamidis Familial amyloid

polyneuropathy

NCB Not

commissioned


use (Double Red)

Tapentadol

immediate release

Moderate to severe pain

according to pathway


use (Double Red)

Tapentadol

prolonged release

Severe chronic pain

according to pathway

CCG Commissioned.

In tariff.


(Amber)

Teduglutide CCG NHSCB is paediatric use

Teduglutide Short bowel syndrome Not commissioned Not commissioned Not recommended for

use (Double Red)

Fund holder to be

confirmed

Tegafur Colorectal cancer National Specialist

Commissioning

Not for primary

care prescribing

TA61 Hospital only

prescribing (Red)

Teicoplanin Targocid IV antibiotic CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Telaprevir Incivo Genotype 1 Chronic

Hepatitis C

National Specialist

Commissioning

Not for primary

care prescribing

TA252 Hospital only

prescribing (Red)


Drugs to NCB

Telbivudine Sebivo Chronic Hepatitis B National Specialist

Commissioning

Not for primary

care prescribing

TA154 NICE not

recommended

41

Issued: April 2013






Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Temozolamide Brain cancer National Specialist

Commissioning

Not commissioned TA23 Hospital only

prescribing (Red)

Temozolamide Glioblastoma multiforme National Specialist

Commissioning

Not for primary

care prescribing

TA121 Hospital only

prescribing (Red)

Temsirolimus RCC Metastatic National Specialist

Commissioning


use (Double Red)

Temsirolimus Relapsed or refractory

mantle cell lymphoma

National Specialist

Commissioning


use (Double Red)


TA207

Tenofovir Viread Chronic Hepatitis B National Specialist

Commissioning

Not for primary

care prescribing

TA173 Hospital only

prescribing (Red)


Drugs to NCB

Tenofovir Viread HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Tenofovir with

Emtricitabine &

Efavirenz

Atripla HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Teriflunomide Multiple Sclerosis

National Specialist

Commissioning

Not for primary

care prescribing

NICE in progress

Teriparatide Forsteo Secondary prevention



women

CCG Commissioned in

line with NICE. Non


Under review TA161 Hospital only

prescribing (Red)


TA161

Testosterone Androgen deficiency CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)

Thalidomide Multiple myeloma First Line National Specialist

Commissioning

Not for primary

care prescribing

TA228 Hospital only

prescribing (Red)

Tigacrelor Brilinta ACS Under review Under review TA236 Under review http://guidance.nice.org.uk/

TA236

Tioguanine All indications National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Tiotropium COPD CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Tipranavir Aptivus HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Tirofiban Aggrastat Prevention MI unstable

angina

CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA47 Hospital only

prescribing (Red)


TA47

42

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Tobramycin NHSE CCG if prescribed by GPs (when delivered via nebulisation/inhalation)

Tobramycin TOBI/Bramit

ob

Cystic fibrosis National Specialist

Commissioning

Not for primary

care prescribing

TA276 All new patients


shared care to be


in line with TAG


TA276

Tocilizumab CCG NHSCB is paediatric use

Tocilizumab RoActemra Rheumatoid arthritis CCG Commissioned.


Not for primary

care prescribing

TA247 Hospital only

prescribing (Red)


TA247

Tocilizumab RoActemra Systemic JIA National Specialist

Commissioning

Not for primary

care prescribing

TA238 Hospital only

prescribing (Red)


TA238

Tofacitinib CCG NHSCB is paediatric use

Tofacitinib Rheumatoid arthritis Not commissioned Not commissioned Not recommended for

use (Double Red)

Tolvaptan Endocrine disorders National Specialist

Commissioning

Not for primary

care prescribing

A3a Endocrinology Hospital only

prescribing (Red)

Tolvaptan Hyponatraemia secondary to

SAIDH

CCG Commissioned.


Not for primary

care prescribing

Hospital only

prescribing (Red)

Topotecan Ovarian cancer (advanced) National Specialist

Commissioning

Not for primary

care prescribing

TA91 Hospital only

prescribing (Red)

Topotecan Relapsed SCLC National Specialist

Commissioning

Not for primary

care prescribing

TA184 Hospital only

prescribing (Red)

Topotecan Stage IVB cervical cancer National Specialist

Commissioning

Not for primary

care prescribing

TA183 Hospital only

prescribing (Red)

Total Parenteral

Nutrition

Intestinal failure CCG Commissioned.


Not for primary

care prescribing

Hospital only

prescribing (Red)

Under NCB guidance

Trabectedin Relapsed ovarian cancer Not commissioned Not commissioned TA222 Not recommended for

use (Double Red)


TA222

Trabectedin Soft tissue sarcoma National Specialist

Commissioning

Not for primary

care prescribing

TA185 Hospital only

prescribing (Red)

Trastuzumab Advanced breast cancer National Specialist

Commissioning

Not for primary

care prescribing

TA34 Hospital only

prescribing (Red)

Trastuzumab HER2 positive breast cancer National Specialist

Commissioning

Not for primary

care prescribing

TA107 Hospital only

prescribing (Red)

43

Issued: April 2013







https://www.engage.commissioningboard.nhs.uk/consultation/ssc-area-a/supporting_documents/a3aservicespec.pdf






Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Trastuzumab HER2 positive breast cancer

with aromatase inhibitor


use (Double Red)

Trastuzumab HER2 positive gastric

cancer

National Specialist

Commissioning

Not for primary

care prescribing

TA208 Hospital only

prescribing (Red)

Treosulfan All indications National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Treprostinil Peripheral Arterial

Hypertension

National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Triptorelin Endometriosis, pre-


uterine fibroids

CCG Commissioned.

In tariff.


(Amber)

Triptorelin Precocius puberty CCG Commissioned.

In tariff.


(Amber)

Triptorelin Prostate cancer CCG Commissioned.

In tariff.

Commissioned Shared care via

Hospital letter

Ulipristal Emergency contraception CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Ulipristal Uterine fibroids CCG Commissioned.

In tariff.


prescribing (Red)

Unlicensed drugs All indications Not commissioned Not commissioned Not recommended for

use (Double Red)

TAG policy is to

discourage 'off-label'

prescribing. Follow GMC

guide to use of unlicensed

medicines. http://www.gmc-

uk.org/guidance/ethical_gu

idance/prescriptions_faqs.

asp#9

Ustekinumab Stelara Severe plaque psoriasis CCG Commissioned.


Not for primary

care prescribing

TA180 Hospital only

prescribing (Red)


TA180

Vaccum dressings Not commissioned Not commissioned Not recommended for

use (Double Red)

Vacuum pumps Erectile Dysfunction CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Valganciclovir Valcyte CMV National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

44

Issued: April 2013




Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Varenicline Smoking cessation CCG Commissioned.

In tariff.


request of Trust

Specialist (Green)


TA123

Various drugs for

erectile dysfunction

Erectile dysfunction CCG Commissioned.

In tariff.


Prescribing (Double

Green)





86.pdf

Various drugs for

erectile dysfunction

Severe distress CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)





86.pdf

Velaglucerase alfa Gauchers National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Vemurafenib Melanoma National Specialist

Commissioning

Not for primary

care prescribing

TA269 Hospital only

prescribing (Red)


TA269

Verteporfin AMD photodynamic therapy CCG Commissioned.

In tariff.

Not for primary

care prescribing

TA68 Hospital only

prescribing (Red)

Vildagliptin T2DM CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Vinflunine Urinary tract carcinoma National Specialist

Commissioning

Not for primary

care prescribing

TA272 NICE not

recommended



TA272

Vinorelbine Advanced breast cancer National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Vinorelbine NSCLC National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Voriconazole Vfend Systemic fungal infections.



National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Warfarin Generic Various CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Yasmin Contraception Not commissioned Not commissioned Not recommended for

use (Double Red)

45

Issued: April 2013








Commissioner

Primary Care

Funding Status

Shared

Care/OtherGuidance


Prescribing




Zaleplon Short term treatment

insomnia

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Zanamavir Treatment & prophylaxis

influenza in at risk groups

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Ziconotide Prialt Intrathecal infusion for

severe pain

National Specialist

Commissioning


use (Double Red)

Zidovudine Retrovir HIV infection National Specialist

Commissioning

Not for primary

care prescribing

Hospital only

prescribing (Red)

Zoledronic acid SRE in plasma cell myeloma CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Zoledronic acid Aclasta Treatment of

postmenopausal

osteoporosis

CCG Commissioned.

In tariff.

Not for primary

care prescribing

Hospital only

prescribing (Red)

Zolpidem Generic Short term treatment

insomnia

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

Zonisamide Zonegran Epilepsy CCG Commissioned.

In tariff.


(Amber)

Zopiclone Generic Short term treatment

insomnia

CCG Commissioned.

In tariff.


Prescribing (Double

Green)

46

Issued: April 2013

combined commissioned drug therapies list · afamelanotide epp not commissioned not commissioned...

Documents